PMDA — authorised 19 January 2005
- Marketing authorisation holder: WYETH LEDERLE JAPAN, WYETH
- Status: approved
PMDA authorised Enbrel on 19 January 2005
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. PMDA authorised it on 19 January 2005.
WYETH LEDERLE JAPAN, WYETH holds the Japanese marketing authorisation.